Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms

Breast Cancer ConclaveПодробнее

DESTINY-Breast03: practice-changing results from ESMO 2021Подробнее

Margetuximab for the treatment of HER2-positive breast cancerПодробнее

Treatment Options for HER2+ Breast Cancer: A Comprehensive GuideПодробнее

Updates on managing HER2-positive early breast cancerПодробнее

HER2-Positive Breast Cancer: A Paradigm Shift in Diagnosis and TherapyПодробнее

Dr. Erika P. Hamilton on The Shifting Treatment Paradigm in HER2-Positive Breast CancerПодробнее

Navigating Shifts in the Treatment Landscape for Metastatic HER2-Positive Breast CancerПодробнее

Tamoxifen: The Drug That Changed Breast Cancer Therapy! Fascinating Drug Discoveries!Подробнее

Treatment approach for metastatic HER2 positive breast cancerПодробнее

Meet the expert : Webinar 3 - Updates in Management Of Her2 Positive Breast CancerПодробнее

How to treat HER2+ Breast Cancer in 2024 with Dr. Harold BursteinПодробнее

Dr Hamilton on Implications of DESTINY-Breast06 on the HER2-Low Breast Cancer ParadigmПодробнее

Dr. Mehta on the Current Treatment Paradigm in HER2-Positive Gastric CancerПодробнее

Clinical Implications of ‘Low’ HER2 Expression: 2023 Best of Breast ConferenceПодробнее

Study of Neratinib for Patients with HER2-Positive Breast Cancer with Brain MetastasesПодробнее

Dual HER2 blockade in patients with HER2-positive breast cancer after pCRПодробнее

Dr. Tolaney on Novel Approaches in Treating HER2-Positive Breast CancerПодробнее

Update from KAITLIN for high-risk HER2-positive early breast cancerПодробнее

Breast Cancer Treatment NYC | Her2 Positive Breast Cancer | Weill Cornell Breast CenterПодробнее